Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review - Supplemental Material

Name: Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review - Supplemental Material
Creator: David Croitoru
Published: 2022-03-03T11:31:12.509Z
Keywords: Dermatology, Rituximab, Pyoderma gangrenosum

Croitoru, David; Nathanielsz, Nikki; Seigel, Kyle; Elsawi, Rawaan; Sibbald, Cathryn; Alavi, Afsaneh; Zipursky, Jonathan; Piguet, Vincent

doi:10.17632/6y7bjwtv6h.2

Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review - Supplemental Material

Published: 3 March 2022| Version 2 | DOI: 10.17632/6y7bjwtv6h.2

Contributors:

David Croitoru, Nikki Nathanielsz, Kyle Seigel, Rawaan Elsawi, Cathryn Sibbald, Afsaneh Alavi, Jonathan Zipursky, Vincent Piguet

Description

Supplemental material for 'Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review'. Each file corresponds to a supplementary table referenced within the article text. Supplementary 1. Probability assessment of rituximab-induced PG based on the Adverse Drug Reaction Probability Scale by Naranjo et al. Supplementary 2. List of included articles and contributory number of cases.

Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review - Supplemental Material

Description

Files

Categories

Licence